Jens Helby: Long-Term Outcomes of Incidentally Detected Thrombocytopenia
Jens Helby, Deputy Head of Department of Clinical Medicine at University of Copenhagen, shared a post on LinkedIn about a recent article by Anne Rudbeck Juhl et al, published in BMJ Medicine, adding:
“I’m happy to share our new article published in BMJ Medicine: ‘Incidentally detected thrombocytopenia and risk of haematological disease and death in the general population’.
In this study of 485 103 general population individuals from the UK and Denmark, we examined the risks of haematological disease, death, and other adverse outcomes after an incidental finding of a low platelet count in blood tests.
In isolated mild thrombocytopenia, absolute risks of death and of being diagnosed with haematological disease were only modestly increased, and all age and sex categories with isolated mild thrombocytopenia had absolute 10-year risks less than 1 percent for death from haematological disease.
Risks were generally more pronounced in isolated moderate-severe thrombocytopenia, and were particularly high in individuals with isolated severe thrombocytopenia or thrombocytopenia with anaemia.
Incidentally detected thrombocytopenia is a common finding (prevalence about 1-2 percent in the general population) that often leads to haematology referral, but evidence has been limited on which individuals are likely to benefit from referral or follow-up.
We therefore hope these absolute risk estimates can support evidence-based clinical decision-making about haematology referral and follow-up.
Congratulations to first author Anne Rudbeck Juhl, and thank you to co-authors Andreas Glenthøj, Børge Nordestgaard, Jesper Petersen, Morten Dahl, Christina Ellervik, and Stig E Bojesen, and to the participants and staff of the UK Biobank, the Copenhagen General Population Study, and the Danish General Suburban Population Study.”
Title: Incidentally detected thrombocytopenia and risk of haematological disease and death in the general population: prospective cohort study
Authors: Anne Rudbeck Juhl, Andreas Glenthøj, Børge Nordestgaard, Jesper Petersen, Morten Dahl, Christina Ellervik, Stig E Bojesen

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction